This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Both, U.
Right arrow Articles by Berner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Both, U.
Right arrow Articles by Berner, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2005, p. 3080-3082, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.3080-3082.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Heterogeneity of Genotype-Phenotype Correlation among Macrolide-Resistant Streptococcus agalactiae Isolates

Ulrich von Both, Anna Buerckstuemmer, Kirsten Fluegge, and Reinhard Berner*

Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, Mathildenstrasse 1, D-79106 Freiburg, Germany

Received 10 February 2005/ Returned for modification 27 March 2005/ Accepted 20 April 2005


arrow
ABSTRACT
 
Seventy-four erythromycin-resistant group B Streptococcus isolates were analyzed regarding their phenotype-genotype and phenotype-serotype correlation. Four different phenotypes were assessed, one of them for the first time. ermB and ermTR were the most frequent genotypes (80%). The most prevalent serotype III showed great phenotypic variability while serotype V was strongly associated only with two different phenotypes.


arrow
TEXT
 
Streptococcus agalactiae (group B Streptococcus [GBS]) is a well-known cause of invasive infections in neonates (3, 15). For treatment or prevention of GBS disease, erythromycin and clindamycin are recommended second-line drugs for patients with ß-lactam allergy (1, 5). In recent years, increasing macrolide resistance rates have been reported for several streptococcal populations worldwide, which is of significant clinical relevance since macrolides are among the most frequently used antibiotics, especially in the pediatric population (9, 11, 12, 13, 14). This resistance is genetically based on either the modification of the ribosome encoded by erm genes (macrolide-lincosamide-streptogramin B [MLSB] phenotype with inducible [i] or constitutive [c] expression) or the efflux of macrolide antibiotics by a mefA-encoded efflux pump (M phenotype). The correlation of specific antimicrobial susceptibility patterns and the respective macrolide resistance genes in streptococci has been an important subject for investigation worldwide (18, 19). To analyze the phenotype-genotype as well as the phenotype-serotype correlation among macrolide resistant GBS isolates, the present study focused on a collection of 74 erythromycin-resistant GBS strains from a southwestern region of Germany collected between the years 1999 and 2004 with 27 of them described previously (20). Briefly, 74 erythromycin-resistant GBS isolates of neonatal origin (cultured from blood, cerebrospinal fluid, urine, and swab cultures) as well as from vaginal swabs of pregnant women were identified using ß-hemolysis testing as well as the Pastorex Strep B agglutination test (Bio-Rad, Marnes-la-Coquette, France). Isolates were subsequently phenotypically analyzed by means of the disk diffusion method and screened by PCR for erythromycin resistance genes (mefA or mefE, ermB, and ermTR) as well as linB using primers previously described (4, 6, 16, 17). PCR assays were reproducibly repeated at least three times for every strain. To differentiate between specific MLS phenotypes, a triple-disk test using erythromycin, clindamycin, and josamycin was performed as previously described (10). Serotyping was performed using an enzymatic extraction method (2).

Results of triple-disk testing revealing four distinct phenotypes are shown in Fig. 1. Thirty-nine isolates (52%) showed the cMLS phenotype (P1) mostly correlated with the ermB resistance gene. Twenty isolates (27%) showed an inducible resistance phenotype (iMLS) with 13 strains exhibiting inducible resistance to clindamycin and josamycin associated with the ermTR gene (P3) and another 7 strains displaying constitutive resistance to clindamycin as well as inducible resistance to josamycin based on either the ermB or the ermTR gene (P2). The M phenotype (P4) could be detected in 15 isolates (20%) strongly associated with the mefA gene (Table 1). All three phenotypes (P1, P3, and P4) correspond well to the ones previously described by different authors (10, 19) while P2, in contrast, has not been described so far. The most prevalent serotypes (ST) among all erythromycin-resistant GBS isolates were ST V (37%) and III (27%) (Table 2). While ST III showed a great variety of different phenotypes, including P2 and P4 (M phenotype), ST V revealed only two different MLS phenotypes (P1 and P3) strongly associated with the ermB or ermTR gene, respectively. Since different studies described the clonal spread of ST V isolates within the GBS population in recent years (8, 20), this might be an explanation for the observed homogeneity of this respective ST V population compared to the ST III isolates in this study. Regarding the newly described P2 phenotype, serotypes Ib and II as well as the predominant serotype III (four of seven isolates) were detected. PCR analysis of these seven isolates revealed either the ermB or the ermTR gene while PCR on linB, a clindamycin resistance gene previously described in GBS by de Azavedo et al. (7) yielded negative results. To our knowledge, there are no data in present literature describing this P2 phenotype as well as its genetic determinant. It is likely to presume that other to date unknown resistance factors or a certain combination of those with known resistance genes is responsible for the heterogeneity of phenotype-genotype correlation among GBS isolates. Such a variety of resistance factors possibly acquired through horizontal gene transfer might as well be responsible for the reported rapid increase of macrolide resistance among GBS isolates.



View larger version (127K):
[in this window]
[in a new window]
  		FIG. 1. Phenotypes of erythromycin-resistant S. agalactiae isolates determined by the triple-disk test. The erythromycin disk (30 µg) is at the center, with the clindamycin disk (10 µg) on the right and the josamycin disk (30 µg) on the left. P1, cMLS phenotype; P2 and P3, iMLS phenotypes; P4, M phenotype.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Distribution of resistance genes among four different phenotypes, P1 to P4a


View this table:
[in this window]
[in a new window]
  		TABLE 2. Distribution of serotypes among four different phenotypes, P1 to P4a


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, Mathildenstrasse 1, D-79106 Freiburg, Germany. Phone: 49-761-270-4480. Fax: 49-761-270-4598. E-mail: berner{at}kikli.ukl.uni-freiburg.de. Back


arrow
REFERENCES
 
    1
  1. American Academy of Pediatrics Committee on Infectious Disease and Committee on Fetus and Newborn. 1997. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99:489-496.[Abstract/Free Full Text]
    2. 2
  2. Berner, R., A. Bender, C. Rensing, J. Forster, and M. Brandis. 1999. Low prevalence of the immunoglobulin-A-binding ß antigen of the C protein among Streptococcus agalactiae isolates causing neonatal sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 18:545-550.[CrossRef][Medline]
    3. 3
  3. Berner, R., R. F. Schumacher, S. Bartelt, J. Forster, and M. Brandis. 1998. Bacteremia in hospitalized children: predisposing conditions and case-related microorganisms. Eur. J. Clin. Microbiol. Infect. Dis. 17:337-340.[Medline]
    4. 4
  4. Bozdogan, B., L. Berrezouga, M.-S. Kuo, D. A. Yurek, K. A. Farley, B. J. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929.[Abstract/Free Full Text]
    5. 5
  5. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbid. Mortal. Wkly. Rep. 45:1-24.
    6. 6
  6. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1998. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 42:1493-1494.
    7. 7
  7. de Azavedo, J. C. S., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.[Abstract/Free Full Text]
    8. 8
  8. Elliot, J. A., K. D. Farmer, and R. R. Facklam. 1998. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J. Clin. Microbiol. 36:2115-2116.[Abstract/Free Full Text]
    9. 9
  9. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibility of group B streptococci isolated between 1992 and 1996 from patients with bacteremia and meningitis. Antimicrob. Agents Chemother. 42:1517-1519.[Abstract/Free Full Text]
    10. 10
  10. Giovanetti, E., M. P. Montanari, M. Mingoia, and P. E. Varaldo. 1999. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.[Abstract/Free Full Text]
    11. 11
  11. Lin, F. Y. C., P. H. Azimi, L. E. Weisman, J. B. Philips III, J. Regan, P. Clark, C. G. Rhoads, J. Clemens, J. Troendle, E. Pratt, R. A. Brenner, and V. Gill. 2000. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. Dis. 31:76-79.[CrossRef][Medline]
    12. 12
  12. Morales, W. J., S. S. Dickey, P. Bornick, and D. V. Lim. 1999. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am. J. Obstet. Gynecol. 181:310-314.[CrossRef][Medline]
    13. 13
  13. Pearlman, M. D., C. L. Piersoni, and R. G. Faix. 1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92:258-261.[CrossRef][Medline]
    14. 14
  14. Rouse, D. J., W. W. Andrews, F. Y. C. Lin, C. W. Mott, J. C. Ware, and J. B. Philips III. 1998. Antibiotic susceptibility profile of group B streptococcus acquired vertically. Obstet. Gynecol. 92:931-934.[CrossRef][Medline]
    15. 15
  15. Schrag, S. J., S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum prophylaxis. N. Engl. J. Med. 342:15-20.[Abstract/Free Full Text]
    16. 16
  16. Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.[Abstract/Free Full Text]
    17. 17
  17. Sutcliffe, J., T. Grebe, T. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.[Abstract]
    18. 18
  18. Uh, Y., I. H. Jang, G. Y. Hwang, M. K. Lee, K. Y. Yoon, and H. Y. Kim. 2004. Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J. Clin. Microbiol. 42:3306-3308.[Abstract/Free Full Text]
    19. 19
  19. Uh, Y., I. H. Jang, G. Y. Hwang, M. K. Lee, K. J. Yoon, and H. Y. Kim. 2004. Antimicrobial susceptibility patterns and macrolide resistance genes of ß-hemolytic streptococci in Korea. Antimicrob. Agents Chemother. 48:2716-2718.[Abstract/Free Full Text]
    20. 20
  20. von Both, U., M. Ruess, U. Mueller, K. Fluegge, A. Sander, and R. Berner. 2003. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J. Clin. Microbiol. 41:2166-2169.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, July 2005, p. 3080-3082, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.3080-3082.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Both, U.
Right arrow Articles by Berner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Both, U.
Right arrow Articles by Berner, R.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»